TB and COVID – Public and private health sectors adapt to a new reality
- Resource Type
- Authors
- Charity Oga-Omenka; Petra Heitkamp; Joel Shyam Klinton
- Source
- Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 21, Iss, Pp 100199-(2020)
- Subject
- 0301 basic medicine
Microbiology (medical)
Pulmonary and Respiratory Medicine
2019-20 coronavirus outbreak
Economic growth
Tuberculosis
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
030106 microbiology
COVID19 and TB
Article
lcsh:Infectious and parasitic diseases
03 medical and health sciences
0302 clinical medicine
Pandemic
medicine
lcsh:RC109-216
030212 general & internal medicine
TBPPM
Health sector
Private Sector Engagement
lcsh:RC705-779
business.industry
lcsh:Diseases of the respiratory system
medicine.disease
Infectious Diseases
business
Healthcare system
- Language
- English
- ISSN
- 2405-5794
Health systems across the world have been baffled by the COVID19 pandemic. Tuberculosis (TB) care and prevention especially in high burden countries has faced disruption to their routine services. Though these setbacks were predicted by many modelling studies, reports and surveys from the field convey the hard reality faced by the TB services. However, health systems have not given up and have become resilient by adapting interesting strategies to overcome these obstacles. The private health sector has also stepped up to the occasion by supporting national TB programs through innovative approaches. The scientific community has laid down several evidence-based recommendations to help TB programs get back on track. Its time to unite these forces to not just overcome the challenge posed by the pandemic but also to build a more resilient health system.